McAlevey Michael R

McAlevey (EVP & Chief Legal & Admin Off.) sold 1,694 shares of HCA at $533.37; holdings drop to 8,853 shares.

Michael R. McAlevey, EVP & Chief Legal & Administrative Officer at HCA Healthcare, sold 1,694 shares at $533.37 on 2026-02-18, reducing his holdings by 16.1% to 8,853 shares and raising $903,536.74. The sale occurs near the 52-week high of $540.29 (within -1.0%), and HCA's stock has gained 14.0% over the prior 30 days and 12.3% over 90 days, suggesting a backdrop of near-peak valuations. However, McAlevey's cross-ticker track record shows a 90-day well-timed rate of 0.00%, and his single prior HCA sale (2025-11-05) delivered a 90-day return of +5.4%, indicating the stock rose after his last sale. HCA fundamentals remain solid with $19.2B in latest quarterly revenue, $1.6B net income, and a reasonable 16.24 P/E ratio, so the sale does not signal fundamental concern. The transaction appears routine relative to the executive's modest historical engagement in open-market activity.

EVP & Chief Legal & Admin Officer sold 3,892 shares of HCA at $473.79, reducing holdings 52.7% to 3,487 shares

Michael R McAlevey, EVP & Chief Legal & Administrative Officer, sold 3,892 shares (3.9K shares) of HCA Healthcare at $473.79 on 2025-11-05, resulting in total proceeds of $1,843,990.68 ($1.8M). This transaction reduced his post-transaction holdings to 3,487 shares (3.5K shares), representing a -52.7% reduction from pre-transaction holdings of 7,379 shares (7.4K shares). The sale occurred at the 52-week high of $473.20, with HCA's stock up 9.2% over 30 days and 26.8% over 90 days, reflecting sustained positive momentum in the security. As a senior legal and administrative officer at a $108.0B market cap healthcare company with solid fundamentals—$19.2B quarterly revenue, $1.6B net income, and 8.7% annual revenue growth—the significant reduction in personal holdings warrants attention for potential changes in executive positioning or liquidity needs.